FDA Makes ‘Suboptimum’ Use Of Advisory Committees, Group Says

FDA is “making suboptimum use of its drug advisory committee system,” according to a letter from the Health Research Group at Public Citizen published in the current issue of the Lancet, USA Today reports. According to the letter, from 2000 through 2004, FDA followed recommendations from advisory committees 72% of the time, and the closeness of the votes of the committees was unrelated to whether the agency followed the recommendations. The letter also states that advisory committees reviewed about 25% of applications for new medications that resulted in approvals from 2000 through June 30, 2006, compared with 40% in 1998 and about 50% in 1999 (USA Today, 1/4).

“Reprinted with permission from http://www.kaisernetwork.org. You can view the entire Kaiser Daily Health Policy Report, search the archives, or sign up for email delivery at http://www.kaisernetwork.org/dailyreports/healthpolicy. The Kaiser Daily Health Policy Report is published for kaisernetwork.org, a free service of The Henry J. Kaiser Family Foundation . © 2005 Advisory Board Company and Kaiser Family Foundation. All rights reserved.

About the Author

admin has written 6390 stories on this site.

Write a Comment

Gravatars are small images that can show your personality. You can get your gravatar for free today!

You must be logged in to post a comment.

Copyright © 2009 Medical News. All rights reserved.
Powered by WordPress.org, Custom Theme and ComFi.com Calling Card Company.
Close